LOVASTATIN-D9
- Product Name
- LOVASTATIN-D9
- CAS No.
- 1002346-03-3
- Chemical Name
- LOVASTATIN-D9
- Synonyms
- LOVASTATIN-D9
- CBNumber
- CB7199437
- Molecular Formula
- C24H36O5
- Formula Weight
- 404.55
- MOL File
- Mol file
LOVASTATIN-D9 Property
- solubility
- Chloroform: slightly soluble
Methanol: slightly soluble
N-Bromosuccinimide Price
- Product number
- 26461
- Product name
- Lovastatin-d9
- Packaging
- 1mg
- Price
- $275
- Updated
- 2024/03/01
LOVASTATIN-D9 Chemical Properties,Usage,Production
Description
Lovastatin-d9 is intended for use as an internal standard for the quantification of lovastatin (Item No. 10010338) by GC- or LC-MS. Lovastatin is a fungal metabolite that has been found in A. terreus and an inhibitor of HMG-CoA reductase (Ki = 1.4 nM).1,2 It is also a prodrug form of the HMG-CoA reductase inhibitor lovastatin hydroxy acid (Item No. 10010339).2 Lovastatin (8 mg/kg per day) reduces plasma cholesterol levels in dogs. It suppresses TNF-induced NF-κB activation (IC50 = ~15 µM) and potentiates apoptosis in human myeloid leukemia cells.3 Lovastatin also increases cellular lipid peroxidation and decreases glutathione peroxidase 4 (GPX4) levels in cancer cells.4 Formulations containing lovastatin have been used in the treatment of hypercholesterolemia.WARNING This product is not for human or veterinary use.
References
[1] ENDO A. The discovery and development of HMG-CoA reductase inhibitors.[J]. Journal of Lipid Research, 1992, 33 11: 1569-1582.
[2] A W ALBERTS. Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.[J]. Proceedings of the National Academy of Sciences of the United States of America, 1980, 77 7: 3957-3961. DOI: 10.1073/pnas.77.7.3957
[3] KWANG SEOK AHN Bharat B A Gautam Sethi. Reversal of chemoresistance and enhancement of apoptosis by statins through down-regulation of the NF-κB pathway[J]. Biochemical pharmacology, 2008, 75 4: Pages 907-913. DOI: 10.1016/j.bcp.2007.10.010
[4] VASANTHI S. VISWANATHAN. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway[J]. Nature, 2017, 547 7664: 453-457. DOI: 10.1038/nature23007
LOVASTATIN-D9 Preparation Products And Raw materials
Raw materials
Preparation Products
LOVASTATIN-D9 Suppliers
- Tel
- 18818260767
- Fax
- QQ 3610331285
- sales@chemegen.com
- Country
- China
- ProdList
- 11218
- Advantage
- 58
- Tel
- 021-69568360 18916172912
- order@med-bio.cn
- Country
- China
- ProdList
- 8140
- Advantage
- 58
- Tel
- 020-3846 2365 19110442770
- 458677837@qq.com
- Country
- China
- ProdList
- 7775
- Advantage
- 58
- Tel
- 800-364-9897
- sales@caymanchem.com
- Country
- China
- ProdList
- 6838
- Advantage
- 58